Nothing Special   »   [go: up one dir, main page]

BR112017000303A2 - métodos para o tratamento de hipotensão - Google Patents

métodos para o tratamento de hipotensão

Info

Publication number
BR112017000303A2
BR112017000303A2 BR112017000303A BR112017000303A BR112017000303A2 BR 112017000303 A2 BR112017000303 A2 BR 112017000303A2 BR 112017000303 A BR112017000303 A BR 112017000303A BR 112017000303 A BR112017000303 A BR 112017000303A BR 112017000303 A2 BR112017000303 A2 BR 112017000303A2
Authority
BR
Brazil
Prior art keywords
methods
treating hypotension
hypotension
treating
relates
Prior art date
Application number
BR112017000303A
Other languages
English (en)
Inventor
Tidmarsh George
Original Assignee
La Jolla Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by La Jolla Pharma Co filed Critical La Jolla Pharma Co
Publication of BR112017000303A2 publication Critical patent/BR112017000303A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

a presente invenção refere-se a presente descrição refere-se ao uso de angiotensina ii nos métodos terapêuticos para o tratamento de hipotensão, especialmente hipotensão resistente à catecolamina.
BR112017000303A 2014-07-08 2015-07-08 métodos para o tratamento de hipotensão BR112017000303A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462022054P 2014-07-08 2014-07-08
PCT/US2015/039499 WO2016007589A1 (en) 2014-07-08 2015-07-08 Methods for treating hypotension

Publications (1)

Publication Number Publication Date
BR112017000303A2 true BR112017000303A2 (pt) 2017-11-07

Family

ID=55064810

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017000303A BR112017000303A2 (pt) 2014-07-08 2015-07-08 métodos para o tratamento de hipotensão

Country Status (14)

Country Link
US (3) US20160074465A1 (pt)
EP (2) EP3007722A4 (pt)
JP (2) JP2017519799A (pt)
KR (1) KR20170026486A (pt)
CN (1) CN106794224A (pt)
AU (2) AU2015287955A1 (pt)
BR (1) BR112017000303A2 (pt)
CA (1) CA2954016A1 (pt)
EA (2) EA036514B1 (pt)
IL (1) IL249936A0 (pt)
MX (1) MX2017000306A (pt)
SG (2) SG10201804034QA (pt)
TW (3) TWI754225B (pt)
WO (1) WO2016007589A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
AU2014364528C1 (en) 2013-12-18 2021-01-07 The George Washington University, A Congressional Chartered Not-For-Profit Corporation Angiotensin ll alone or in combination for the treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
CA3010781A1 (en) 2016-01-07 2017-07-13 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
US11583568B2 (en) 2017-04-14 2023-02-21 La Jolla Pharma, Llc Methods for administering angiotensin II
TW201927331A (zh) * 2017-12-15 2019-07-16 美商拉荷亞製藥公司 血管收縮素組合物及與其相關之方法
US10653646B2 (en) * 2018-03-23 2020-05-19 Nevakar Inc. Epinephrine compositions and containers
KR102258546B1 (ko) 2018-10-26 2021-06-01 양성심 유기농 케일을 주 성분으로 하는 건강기능식품 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
ATE507243T1 (de) * 2005-09-29 2011-05-15 Fibrogen Inc Verfahren zur senkung des blutdrucks
AU2009319856A1 (en) * 2008-11-28 2010-06-03 Abbvie Inc. Stable antibody compositions and methods for stabilizing same
US9572856B2 (en) * 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
AU2014364528C1 (en) * 2013-12-18 2021-01-07 The George Washington University, A Congressional Chartered Not-For-Profit Corporation Angiotensin ll alone or in combination for the treatment of hypotension

Also Published As

Publication number Publication date
US20180311306A1 (en) 2018-11-01
EA202091873A2 (ru) 2020-11-30
JP2017519799A (ja) 2017-07-20
JP2020143139A (ja) 2020-09-10
AU2021201669A1 (en) 2021-04-08
TW202214219A (zh) 2022-04-16
US20160074465A1 (en) 2016-03-17
IL249936A0 (en) 2017-03-30
EA202091873A3 (ru) 2021-01-29
EP3381465A1 (en) 2018-10-03
EA201692534A1 (ru) 2017-06-30
WO2016007589A1 (en) 2016-01-14
TW201625231A (zh) 2016-07-16
US20200237853A1 (en) 2020-07-30
SG10201804034QA (en) 2018-07-30
CA2954016A1 (en) 2016-01-14
EP3007722A1 (en) 2016-04-20
AU2015287955A1 (en) 2017-02-02
KR20170026486A (ko) 2017-03-08
TW202038927A (zh) 2020-11-01
EP3007722A4 (en) 2016-05-25
CN106794224A (zh) 2017-05-31
TWI754225B (zh) 2022-02-01
EA036514B1 (ru) 2020-11-18
SG11201610897VA (en) 2017-01-27
TWI688385B (zh) 2020-03-21
MX2017000306A (es) 2017-07-10

Similar Documents

Publication Publication Date Title
BR112019006160A2 (pt) composições e métodos para o tratamento das condições oftálmicas
BR112017000303A2 (pt) métodos para o tratamento de hipotensão
DK3389778T3 (da) Indretning til fotodynamisk behandling
DK3212670T3 (da) Kombinationsterapi mod cancer
BR112017008399A2 (pt) abordagem de imunoterapia de combinação para tratamento de câncer
BR112019007613A2 (pt) terapia de combinação para inibição de c3
BR112017011771A2 (pt) métodos e composições para o tratamento de câncer
EA201891340A1 (ru) Лечение рака с использованием 2-дезокси-2-фтор-l-фукозы в комбинации с ингибитором контрольных точек
KR20180084772A (ko) 암 치료를 위한 조합 치료법
BR112016016792A2 (pt) Aparelho para tratamento de vestuário
BR112016017112A2 (pt) Composições de apilimod e métodos de uso das mesmas
BR112018005409A2 (pt) terapêutica de glicodirecionamento.
BR112018000776A2 (pt) métodos para tratamento de câncer usando apilimod
BR112017008799A2 (pt) composições de apilimod e métodos de uso das mesmas no tratamento de câncer renal
DK4119569T3 (da) Konjugerede antisense-forbindelser til anvendelse i behandling
BR112018012313A2 (pt) composições que compreendem 15-hepe e métodos para uso das mesmas
DK3296485T3 (da) Ståldrager
DK3393478T3 (da) Kombinationsterapi
BR112016029236A2 (pt) métodos para tratar prurido.
BR112018012116A2 (pt) terapia intravesical para câncer de bexiga
BR112017001384A2 (pt) composto para uso em tratamento anti-helmíntico
BR112018013847A2 (pt) métodos para administrar a angiotensina ii
BR112019006504A2 (pt) regime de dosagem de avelumabe para o tratamento de câncer
BR112017025264A2 (pt) tratamento de prurido
BR112017017883A2 (pt) doses e métodos para administrar telavancina

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.